Status:
COMPLETED
Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid
Lead Sponsor:
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Conditions:
Choroidal Neovascularization
Choroid Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study will evaluate patients with diagnosis of polypoidal choroidal vasculopathy (PCV) in pachychoroid treated with combined therapy, consisting in photodynamic therapy (PDT) and 3 intravitreal t...
Detailed Description
This study evaluates patients with diagnosis of polypoidal choroidal vasculopathy (PCV) in pachychoroid treated with combined therapy, consisting in photodynamic therapy (PDT) and 3 intravitreal thera...
Eligibility Criteria
Inclusion
- presence of haemorrhagic or exudative PCV diagnosed by OCT and ICGA
- Mean central choroidal thickness \> 250 µm
Exclusion
- ocular comorbidity
- previous cardiovascular events
- different ocular surgical procedures form cataract surgery
Key Trial Info
Start Date :
September 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 13 2019
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04075188
Start Date
September 18 2017
End Date
July 13 2019
Last Update
September 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Palermo, Italy, 90127